The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40

BACKGROUND: NRG Oncology/NSABP trial B-40 tested the impact of adding bevacizumab (bev) to neoadjuvant chemotherapy for operable breast cancer. Secondary endpoints included rates of surgical complications after surgery in patients who did or did not receive bev. METHODS: 1206 women with HER2-negativ...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ann Surg Oncol
Main Authors: Bear, Harry D., Tang, Gong, Rastogi, Priya, Geyer, Charles E., Zoon, Christine K., Kidwell, Kelley M., Robidoux, André, Baez-Diaz, Luis, Brufsky, Adam M., Mehta, Rita S., Fehrenbacher, Louis, Young, James A., Senecal, Francis M., Gaur, Rakesh, Margolese, Richard G., Adams, Paul T., Gross, Howard M., Costantino, Joseph P., Paik, Soonmyung, Swain, Sandra M., Mamounas, Eleftherios P., Wolmark, Norman
格式: Artigo
語言:Inglês
出版: 2016
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5821429/
https://ncbi.nlm.nih.gov/pubmed/27864694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5662-9
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍